Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved (Hep C Chronic Fatigue)

Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved
Medical News Today - Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in

Medical News Story
News-Medical.Net - Researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate for hepatitis C, leading to hope in the fight against a disease for which no vaccines are yet available. VIDO is the

Organ Donor Rates for 2005 Worst Ever
Scoop - Organ Donor Rates for 2005 Worst Ever. Figures released today show that New Zealand has hit an all time low in the number of organ donors it has. Just 29 people became organ donors in 2005. The previous lowest was 34 donors, more than 16 years ago

Idenix and Novartis announce new drug application submitted to the U.S
WebWire - East Hanover, NJ, January 3, 2006 - Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) and Novartis Pharmaceuticals Corporation (NYSE: NVS) announced today that a New Drug Application (NDA) was submitted to the United States Food and Drug Administration